Literature DB >> 24569620

Ovarian estradiol production and lipid metabolism in postmenopausal women.

Risa Maruoka1, Akiko Tanabe, Ayako Watanabe, Kiyoko Nakamura, Keisuke Ashihara, Tomohito Tanaka, Yoshito Terai, Masahide Ohmichi.   

Abstract

OBJECTIVE: Menopause is defined as the permanent cessation of menses. Although previous studies demonstrated a slight production of androgens and estrogens by postmenopausal ovaries, the impact of hormone production on lipid metabolism is still uncertain. The aim of this study was to evaluate whether the postmenopausal ovary is hormonally active and whether hormone status contributes to lipid metabolism.
METHODS: This was a prospective study of 87 women who were treated for gynecological diseases (29% had cervical cancer, 49% had endometrial cancer, 7% had fibroid tumors, and 15% had cervical intraepithelial neoplasia). They were categorized as early postmenopausal (n = 40; mean [SD], 56.8 [3.8] y) or late postmenopausal (n = 47; mean [SD], 66.6 [5.7] y) women. Serum specimens were collected from the peripheral and ovarian veins of participants undergoing bilateral oophorectomy. Sex steroid hormone levels and lipid profiles were determined.
RESULTS: Statistically significant differences in estradiol (E2) and testosterone were seen between the ovarian samples and the peripheral samples in all groups. E2 and estrone obtained from ovarian venous samples gradually decreased with age in postmenopausal women. There was a significant correlation between ovarian E2 and high-density lipoprotein cholesterol levels and the low-density lipoprotein-to-high-density lipoprotein ratio. However, there was no correlation between peripheral E2 levels and any of the lipid parameters examined.
CONCLUSIONS: Although this study investigates women with gynecological diseases, the postmenopausal ovary is hormonally active, and the E2 produced by postmenopausal ovaries may therefore contribute to the maintenance of lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569620     DOI: 10.1097/GME.0000000000000221

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  3 in total

1.  Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.

Authors:  Kassondra S Grzankowski; J Brian Szender; Chandra L Spring-Robinson; Shashikant B Lele; Kunle O Odunsi; Peter J Frederick
Journal:  Int J Gynecol Cancer       Date:  2016-10       Impact factor: 3.437

Review 2.  The impact of aging on innate and adaptive immunity in the human female genital tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Zheng Shen; Charles R Wira
Journal:  Aging Cell       Date:  2021-05-05       Impact factor: 9.304

3.  Determining the Optimal Cut-Off Values of Serum E2 and FSH for Evaluating the Menopausal Status of Breast Cancer Patients in a Southern Chinese Population.

Authors:  Lu Yang; Rucai Li; Mengsi Yu; Fen Huang; Jiangzheng Zeng; Yanda Lu; Changcheng Yang
Journal:  Dis Markers       Date:  2022-08-21       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.